We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
601
Illinois Tool Works
ITW
$81.4B
$928K 0.03%
7,745
-249
-3% -$28.9K
UN
602
DELISTED
Unilever NV New York Registry Shares
UN
$926K 0.03%
20,097
+1,481
+8% +$68.3K
OLN icon
603
Olin
OLN
$2.64B
$924K 0.03%
44,998
-12,181
-21% -$262K
IJS icon
604
iShares S&P Small-Cap 600 Value ETF
IJS
$8.11B
$919K 0.03%
14,734
+1,770
+14% +$109K
MDC
605
DELISTED
M.D.C. Holdings, Inc.
MDC
$918K 0.03%
49,409
+4,028
+9% +$74.9K
MOH icon
606
Molina Healthcare
MOH
$10.3B
$917K 0.03%
15,718
-686
-4% -$37.8K
CCOI icon
607
Cogent Communications
CCOI
$594M
$905K 0.03%
24,588
-9,286
-27% -$359K
NHC icon
608
National Healthcare
NHC
$3.53B
$903K 0.03%
13,678
EFAV icon
609
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.22B
$899K 0.03%
13,285
+2,187
+20% +$147K
XLP icon
610
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$896K 0.03%
16,851
-3,363
-17% -$183K
DY icon
611
Dycom Industries
DY
$12.9B
$895K 0.03%
10,949
-700
-6% -$61.8K
AXON
612
Axon Enterprise
AXON
$40.5B
$890K 0.03%
31,105
+9,840
+46% +$273K
LNC icon
613
Lincoln National
LNC
$7.91B
$888K 0.03%
18,896
+4,235
+29% +$190K
SNY icon
614
Sanofi
SNY
$104B
$884K 0.03%
23,152
-2,965
-11% -$119K
TKR icon
615
Timken Company
TKR
$9.82B
$884K 0.03%
25,150
-350
-1% -$11.5K
RAD
616
DELISTED
Rite Aid Corporation
RAD
$883K 0.03%
5,736
+670
+13% +$100K
GATX icon
617
GATX Corp
GATX
$6.55B
$881K 0.03%
19,768
-300
-1% -$13.2K
ARI
618
Apollo Commercial Real Estate
ARI
$887M
$875K 0.03%
53,499
+11,375
+27% +$187K
HLT icon
619
Hilton Worldwide
HLT
$74B
$875K 0.03%
12,728
-5,334
-30% -$376K
KMPR icon
620
Kemper
KMPR
$1.7B
$873K 0.03%
22,210
VGT icon
621
Vanguard Information Technology ETF
VGT
$139B
$866K 0.03%
57,576
+3,088
+6% +$44.8K
CALY
622
Callaway Golf Company
CALY
$3.26B
$865K 0.03%
74,500
-354,950
-83% -$3.96M
OC icon
623
Owens Corning
OC
$11.5B
$859K 0.03%
16,084
-121
-0.7% -$6.5K
LSXMA
624
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$859K 0.03%
34,972
-332
-0.9% -$8.07K
CTAS icon
625
Cintas
CTAS
$82.4B
$854K 0.02%
30,372

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.